Costus afer: A Systematic Review of Evidence-Based Data in support of Its Medicinal Relevance

Joint Authors

Quasie, O.
Adinortey, Cynthia Ayefoumi
Adinortey, Michael Buenor
Agbeko, Rosemary
Boison, Daniel
Babanyinah, Godwin Kweku
Wiabo-Asabil, Gilbert Kofi

Source

Scientifica

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-10, 10 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-12-27

Country of Publication

Egypt

No. of Pages

10

Main Subjects

Diseases

Abstract EN

Costus afer (C.

afer) is a plant commonly known as ginger lily, spiral ginger, or bush cane.

It is reportedly used in traditional medicine practice (TMP) to treat and manage many ailments including diabetes mellitus, stomach ache, arthritis, inflammation, and gout.

These purported ethnomedicinal uses have triggered many research studies on the plant to amass scientific evidence.

However, these research reports are scattered, and thus, this systematic review seeks to provide a comprehensive update on it covering its traditional uses, phytochemical and nutritional constituents, pharmacological activities, and toxicological effects.

An online search was done using search engines such as Google Scholar, PubMed, and ScienceDirect from the period 1970 to 2019.

The online search included the use of keywords, “Costus afer Ker-Gawl” or “Costus afer.” The search revealed that the stem and leaves of the plant contain substantial amounts of micronutrients and macronutrients.

The leaves, stem, rhizomes, and roots of C.

afer contain several steroidal sapogenins, aferosides, dioscin, and paryphyllin C and flavonoid glycoside kaempferol-3-O-α-L-rhamnopyranoside.

Experimental studies on various parts of the plant showed bioactivities such as antihyperglycemic, hepatocellular protection, cardioprotection, nephroprotection, testicular protection, CNS depressant, analgesic, antiarthritis, antibacterial, and antioxidant.

Based on these evident data, it is concluded that the plant could be used as an alternative and complementary therapy for many oxidative stress-related diseases, provided further scientific studies on the toxicological and pharmacological aspects are carried out.

American Psychological Association (APA)

Boison, Daniel& Adinortey, Cynthia Ayefoumi& Babanyinah, Godwin Kweku& Quasie, O.& Agbeko, Rosemary& Wiabo-Asabil, Gilbert Kofi…[et al.]. 2019. Costus afer: A Systematic Review of Evidence-Based Data in support of Its Medicinal Relevance. Scientifica،Vol. 2019, no. 2019, pp.1-10.
https://search.emarefa.net/detail/BIM-1210163

Modern Language Association (MLA)

Boison, Daniel…[et al.]. Costus afer: A Systematic Review of Evidence-Based Data in support of Its Medicinal Relevance. Scientifica No. 2019 (2019), pp.1-10.
https://search.emarefa.net/detail/BIM-1210163

American Medical Association (AMA)

Boison, Daniel& Adinortey, Cynthia Ayefoumi& Babanyinah, Godwin Kweku& Quasie, O.& Agbeko, Rosemary& Wiabo-Asabil, Gilbert Kofi…[et al.]. Costus afer: A Systematic Review of Evidence-Based Data in support of Its Medicinal Relevance. Scientifica. 2019. Vol. 2019, no. 2019, pp.1-10.
https://search.emarefa.net/detail/BIM-1210163

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1210163